Roth Capital Downgrades LifeCell Corp. (LIFC) to Hold
Roth Capital downgrades LifeCell Corp. (Nasdaq: LIFC) from Buy to Hold.
LifeCell Corporation develops, processes and markets biological soft tissue repair products made from human (allograft) and animal (xenograft) tissue.[SM]
Related Categories
DowngradesStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
